Suministro de Uroquinasa (DOE) y Natalizumab (DOE)
Awarded
The competition has ended and a winner has been selected.
- Deadline
- Jun 15,Expired
- Award
- Agreement
- Buying goodsover 1 year
Brief
OSAKIDETZA - Servicio Vasco de Salud - Organización Central ha modificado un contrato con BIOGEN IDEC IBERIA, S.L. para el suministro de Uroquinasa (DOE) y Natalizumab (DOE) en España. El contrato tiene una duración de 1 año y un valor final de 235.708 €.
Farmasøytisk engroshandel
Result
- BIOGEN IDEC IBERIA, S.L.Winner
- 0Number of tenders received
- €235,708Contract value
Previous winners
Who are you up against?
The suppliers who have won similar contracts at OSAKIDETZA - Servicio Vasco de Salud - Hospital Universitario Cruces (Impulsora)
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Identificación del acondicionamiento primario del medicamento para su dispensación en dosis unitaria
Source
No source found in the documents. Check the weight against the tender documents.
From the notice
Suministro de Uroquinasa (DOE) y Natalizumab (DOE)
Contact
Servicio de Farmaciacontrata@osakidetza.eus- ResultType
- Araba/ÁlavaLocation
- 33600000Main codePharmaceutical products